IBMC•INEB ASSOCIATED INSTITUTIONS:
 

	Centro de Performance Humana

MEMBERSHIPS AND PARTNERSHIPS:
IBMC•INEB or its members are committed on providing advice on science policy decisions as a member of several organizations:

Carnegie Mellon Programme
Conselho Nacional de Laboratórios Associados
EIBIR European Institute for Biomedical Imaging Research
EMBO
European Technology Platform – Nanomedicine
Harvard-Portugal Program
Health Cluster Portugal
MIT Portugal Program
National Agency Ciência Viva
ORPHANET

NETWORK ACTIONS:
IBMC•INEB researchers have also successfully participated in several networking programs. Many cross-research activities were performed as outlined in the on-going funded research networks that are listed below:

Ação Integrada Luso-Espanhola nº E-49/09, E-21/11, E-22/11
ADI-Nanoforbone-QREN
Biobanking and Biomolecular Research Infrastructure (BBRI)
COST actions: CM0801, CM1001, FA1006
ERA-IB IMMUNOTEC
ERA-NETs: New Indigo Tricont; Pathogenomics project; Plant Genomics
EuroGentest 2 – Genetic Testing in Europe (NoE, FP7)
European Huntington’s Disease Network
FCT/CAPES
Genetic Testing Group on Huntington Disease
HD Modifiers in Age of Onset in Pairs of Siblings
Human Frontiers Science Program
IMMUNONET, INBIOTEC, INTERREG IVB/SUDOE
NMP4-LA-2009-228827 Nanofol
Portugal-France Cooperation
REMEDIC – Regenerative Medicine. European Science Foundation Research Network Programme
RIBERMOV - Iberoamerican Network: Parkinson’s Disease and Spinocerebellar Ataxias
SCAbase –spinocerebellar ataxias”, created to assist quality molecular genetics diagnosis of SCAs
SPATAX – Raiseau Européen de Ataxies et Paraplegies Working Group 1 “Molecular Biology of Pathogenic Trypanosomatidae

TRANSLATION AND SOCIAL DEVELOPMENT NETWORKING:
IBMC•INEB teams, in pursuing socially initiatives and platforms that have a significant impact on the public, either specialized or lay public:

Biomaterials Network
Biomatter
Biomedical Implants
Biosense
Ciência 2.0
Eurogene – a European reference site for genetic medicine
RD Portal ORPHANET –Rare Diseases and Orphan Drugs